Medical - Distribution
Compare Stocks
4 / 10Stock Comparison
WGRX vs HCSG vs HSIC vs AMSF
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Distribution
Insurance - Specialty
WGRX vs HCSG vs HSIC vs AMSF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Distribution | Medical - Care Facilities | Medical - Distribution | Insurance - Specialty |
| Market Cap | $8M | $1.60B | $8.09B | $569M |
| Revenue (TTM) | $6M | $1.84B | $13.18B | $325M |
| Net Income (TTM) | $-73M | $59M | $398M | $46M |
| Gross Margin | 4.1% | 13.3% | 29.1% | 47.6% |
| Operating Margin | -12.1% | 3.0% | 5.8% | 17.8% |
| Forward P/E | — | 21.3x | 13.2x | 14.5x |
| Total Debt | $25M | $25M | $3.69B | $491K |
| Cash & Equiv. | $1M | $161M | $156M | $62M |
WGRX vs HCSG vs HSIC vs AMSF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 25 | May 26 | Return |
|---|---|---|---|
| Wellgistics Health,… (WGRX) | 100 | 3.1 | -96.9% |
| Healthcare Services… (HCSG) | 100 | 219.6 | +119.6% |
| Henry Schein, Inc. (HSIC) | 100 | 98.1 | -1.9% |
| AMERISAFE, Inc. (AMSF) | 100 | 59.0 | -41.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WGRX vs HCSG vs HSIC vs AMSF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WGRX lags the leaders in this set but could rank higher in a more targeted comparison.
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs WGRX's -91.8%
- +55.8% vs WGRX's -98.0%
- 7.3% ROA vs WGRX's -138.4%, ROIC 9.0% vs -32.2%
HSIC is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.73
- Beta 0.73, current ratio 1.38x
- Lower P/E (13.2x vs 14.5x)
AMSF is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 31.8% 10Y total return vs HSIC's 5.3%
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- 14.3% margin vs WGRX's -13.0%
- Beta 0.23 vs HCSG's 1.12, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs WGRX's -91.8% | |
| Value | Lower P/E (13.2x vs 14.5x) | |
| Quality / Margins | 14.3% margin vs WGRX's -13.0% | |
| Stability / Safety | Beta 0.23 vs HCSG's 1.12, lower leverage | |
| Dividends | 8.4% yield; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +55.8% vs WGRX's -98.0% | |
| Efficiency (ROA) | 7.3% ROA vs WGRX's -138.4%, ROIC 9.0% vs -32.2% |
WGRX vs HCSG vs HSIC vs AMSF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
WGRX vs HCSG vs HSIC vs AMSF — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCSG leads in 2 of 6 categories
AMSF leads 1 • WGRX leads 1 • HSIC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HSIC is the larger business by revenue, generating $13.2B annually — 2346.3x WGRX's $6M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to WGRX's -13.0%. On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6M | $1.8B | $13.2B | $325M |
| EBITDAEarnings before interest/tax | -$65M | $72M | $1.1B | $58M |
| Net IncomeAfter-tax profit | -$73M | $59M | $398M | $46M |
| Free Cash FlowCash after capex | -$7M | $139M | $561M | $8M |
| Gross MarginGross profit ÷ Revenue | +4.1% | +13.3% | +29.1% | +47.6% |
| Operating MarginEBIT ÷ Revenue | -12.1% | +3.0% | +5.8% | +17.8% |
| Net MarginNet income ÷ Revenue | -13.0% | +3.2% | +3.0% | +14.3% |
| FCF MarginFCF ÷ Revenue | -130.5% | +7.6% | +4.3% | +2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -80.9% | +6.6% | +7.7% | +10.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -11.8% | +175.0% | +14.9% | -8.5% |
Valuation Metrics
WGRX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 55% valuation discount to HCSG's 27.5x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8M | $1.6B | $8.1B | $569M |
| Enterprise ValueMkt cap + debt − cash | $32M | $1.5B | $11.6B | $508M |
| Trailing P/EPrice ÷ TTM EPS | -0.68x | 27.54x | 21.56x | 12.27x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.30x | 13.25x | 14.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 6.84x | — |
| EV / EBITDAEnterprise value multiple | — | 22.38x | 10.87x | 8.53x |
| Price / SalesMarket cap ÷ Revenue | 0.44x | 0.87x | 0.61x | 1.80x |
| Price / BookPrice ÷ Book value/share | 0.68x | 3.19x | 1.79x | 2.30x |
| Price / FCFMarket cap ÷ FCF | — | 11.49x | 14.12x | 63.83x |
Profitability & Efficiency
Evenly matched — HCSG and AMSF each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-11 for WGRX. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to WGRX's 3.73x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs HSIC's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.8% | +11.8% | +8.2% | +9.7% |
| ROA (TTM)Return on assets | -138.4% | +7.3% | +3.6% | +5.6% |
| ROICReturn on invested capital | -32.2% | +9.0% | +7.1% | +21.9% |
| ROCEReturn on capital employed | -73.4% | +7.7% | +9.8% | +16.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 4 | 7 |
| Debt / EquityFinancial leverage | 3.73x | 0.05x | 0.77x | 0.00x |
| Net DebtTotal debt minus cash | $24M | -$136M | $3.5B | -$61M |
| Cash & Equiv.Liquid assets | $1M | $161M | $156M | $62M |
| Total DebtShort + long-term debt | $25M | $25M | $3.7B | $491,000 |
| Interest CoverageEBIT ÷ Interest expense | -10.95x | 33.02x | 4.59x | — |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HSIC five years ago would be worth $8,746 today (with dividends reinvested), compared to $232 for WGRX. Over the past 12 months, HCSG leads with a +55.8% total return vs WGRX's -98.0%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs WGRX's -71.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -79.7% | +28.6% | -8.2% | -18.3% |
| 1-Year ReturnPast 12 months | -98.0% | +55.8% | +5.9% | -29.2% |
| 3-Year ReturnCumulative with dividends | -97.7% | +48.6% | -11.7% | -24.8% |
| 5-Year ReturnCumulative with dividends | -97.7% | -21.1% | -12.5% | -18.9% |
| 10-Year ReturnCumulative with dividends | -97.7% | -26.8% | +5.3% | +31.8% |
| CAGR (3Y)Annualised 3-year return | -71.5% | +14.1% | -4.0% | -9.1% |
Risk & Volatility
Evenly matched — HCSG and AMSF each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs WGRX's 1.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.99x | 1.14x | 0.72x | 0.21x |
| 52-Week HighHighest price in past year | $7.04 | $24.39 | $89.29 | $48.54 |
| 52-Week LowLowest price in past year | $0.08 | $12.66 | $61.95 | $29.42 |
| % of 52W HighCurrent price vs 52-week peak | +1.3% | +91.5% | +79.0% | +62.4% |
| RSI (14)Momentum oscillator 0–100 | 31.2 | 61.8 | 39.1 | 34.2 |
| Avg Volume (50D)Average daily shares traded | 13.8M | 676K | 1.2M | 212K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: HCSG as "Hold", HSIC as "Hold", AMSF as "Buy". Consensus price targets imply 46.9% upside for AMSF (target: $45) vs 9.8% for HCSG (target: $25). AMSF is the only dividend payer here at 8.41% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $24.50 | $85.43 | $44.50 |
| # AnalystsCovering analysts | — | 15 | 32 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +8.4% |
| Dividend StreakConsecutive years of raises | — | 20 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $2.55 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.9% | +10.5% | +2.1% |
HCSG leads in 2 of 6 categories (Total Returns, Analyst Outlook). AMSF leads in 1 (Income & Cash Flow). 2 tied.
WGRX vs HCSG vs HSIC vs AMSF: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WGRX or HCSG or HSIC or AMSF a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 5x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WGRX or HCSG or HSIC or AMSF?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus Healthcare Services Group, Inc. at 27. 5x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — WGRX or HCSG or HSIC or AMSF?
Over the past 5 years, Henry Schein, Inc.
(HSIC) delivered a total return of -12. 5%, compared to -97. 7% for Wellgistics Health, Inc. (WGRX). Over 10 years, the gap is even starker: AMSF returned +31. 9% versus WGRX's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WGRX or HCSG or HSIC or AMSF?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 21β versus Healthcare Services Group, Inc. 's 1. 14β — meaning HCSG is approximately 452% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 4% for Wellgistics Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — WGRX or HCSG or HSIC or AMSF?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -116. 7% for Wellgistics Health, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WGRX or HCSG or HSIC or AMSF?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus -37. 8% for Wellgistics Health, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus -33. 9% for WGRX. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WGRX or HCSG or HSIC or AMSF more undervalued right now?
On forward earnings alone, Henry Schein, Inc.
(HSIC) trades at 13. 2x forward P/E versus 21. 3x for Healthcare Services Group, Inc. — 8. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 46. 9% to $44. 50.
08Which pays a better dividend — WGRX or HCSG or HSIC or AMSF?
In this comparison, AMSF (8.
4% yield) pays a dividend. WGRX, HCSG, HSIC do not pay a meaningful dividend and should not be held primarily for income.
09Is WGRX or HCSG or HSIC or AMSF better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 9%, HCSG: -24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WGRX and HCSG and HSIC and AMSF?
These companies operate in different sectors (WGRX (Healthcare) and HCSG (Healthcare) and HSIC (Healthcare) and AMSF (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: WGRX is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; HSIC is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock. AMSF pays a dividend while WGRX, HCSG, HSIC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.